Understanding the Burden of Atopic Dermatitis in Africa and the Middle East

被引：32

作者：

Al-Afif, Khalid Abdullah Mohammad ^{[1
]}

Buraik, Mohamad Ali ^{[2
]}

Buddenkotte, Joerg ^{[3
,4
]}

Mounir, Mohamed ^{[5
,6
,7
]}

Gerber, Robert ^{[8
,9
,10
]}

Ahmed, Haytham Mohamed ^{[11
,12
,13
]}

Tallman, Anna M. ^{[14
]}

Steinhoff, Martin ^{[3
,4
,15
,16
,17
]}

机构：

[1] Al Noor Specialist Hosp, Mecca, Saudi Arabia

[2] King Fand Cent Hosp, Dept Dermatol, Jizan, Saudi Arabia

[3] Hamad Med Corp, Dept Dermatol, Doha, Qatar

[4] Hamad Med Corp, HMC Translat Res Inst, Doha, Qatar

[5] Pfizer Inc, Dept Inflammat, Dubai, U Arab Emirates

[6] Pfizer Inc, Dept Immunol, Dubai, U Arab Emirates

[7] Pfizer Inc, Dept Emerging Markets, Dubai, U Arab Emirates

[8] Pfizer Inc, Dept Outcomes, Groton, CT 06340 USA

[9] Pfizer Inc, Dept Evidence, Groton, CT 06340 USA

[10] Pfizer Inc, Dept Stat, Groton, CT 06340 USA

[11] Pfizer Inc, Dept Inflammat, Jeddah, Saudi Arabia

[12] Pfizer Inc, Dept Immunol, Jeddah, Saudi Arabia

[13] Pfizer Inc, Dept Markets, Jeddah, Saudi Arabia

[14] Pfizer Inc, Global Med Affairs, New York, NY USA

[15] Weill Cornell Med Qatar, Doha, Qatar

[16] Qatar Univ, Doha, Qatar

[17] Weill Cornell Univ, Dept Dermatol, New York, NY USA

来源：

DERMATOLOGY AND THERAPY | 2019年 / 9卷 / 02期

关键词：

Africa; Atopic dermatitis; Middle East; Prevalence; Quality of life; Therapeutics; QUALITY-OF-LIFE; LONG-TERM SAFETY; RISK-FACTORS; INTESTINAL MICROFLORA; CRISABOROLE OINTMENT; EUROPEAN GUIDELINES; CREAM; 1-PERCENT; ARABIC VERSION; CHILDREN; ECZEMA;

D O I：

10.1007/s13555-019-0285-2

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Atopic dermatitis (AD) is a common inflammatory skin disease characterized by intensely pruritic lesions. The prevalence of atopic dermatitis is increasing in developing regions, including Africa and the Middle East. However, these regions are under-represented in the dermatology literature, and a better understanding of the growing burden of atopic dermatitis in Africa and the Middle East is necessary. Herein, we summarize current knowledge on atopic dermatitis epidemiology, disease burden, and treatment options in Africa and the Middle East, highlighting the unmet needs of patients in these regions. With these needs in mind, we provide clinical recommendations for appropriate management of atopic dermatitis in Africa and the Middle East.

引用

页码：223 / 241

页数：19

共 99 条

[1] Quality of life in patients with skin diseases in central Saudi Arabia
Abolfotouh, Mostafa A.
Al-Khowailed, Mohammad S.
Suliman, Wijdan E.
Al-Turaif, DeemaA
Al-Bluwi, Eman
Al-Kahtani, Hassan S.
[J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2012, 5 : 633 - 642
[2] Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
Aghaei, Shahin
[J]. BMC DERMATOLOGY, 2005, 5
[3] Ahmed Anwar E, 2016, Sultan Qaboos Univ Med J, V16, pe217, DOI 10.18295/squmj.2016.16.02.013
[4] Al Robaee AA, 2010, ACTA DERMATOVENER CR, V18, P243
[5] The Impact of Childhood Atopic Dermatitis on the Patients' Family
Al Shobaili, Hani A.
[J]. PEDIATRIC DERMATOLOGY, 2010, 27 (06) : 618 - 623
[6] Al-Hoqail IA, 2009, J FAM COMMUNITY MED, V16, P105
[7] Arabic version of Skindex-16: Translation and cultural adaptation, with assessment of reliability and validity
AlGhamdi, Khalid M.
AlShammari, Sulaiman A.
[J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2007, 46 (03) : 247 - 252
[8] The Prevalence of Anxiety and Depression in Arab Dermatology Patients
AlShahwan, Mohammed A.
[J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (03) : 297 - 303
[9] Alzolibani AA, 2014, SAUDI MED J, V35, P391
[10] Anvar M, 2010, IRAN J PSYCHIATRY BE, V4, P47

← 1 2 3 4 5 6 7 8 9 10 →